← Leaderboards
Stella Kang
New York University School Of Medicine
$5,102,891
Attributed
$5,102,891
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,102,891 · 3
By mechanism
R01$4,071,207 · 2
K07$1,031,684 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Richard Bernard Hayes$7,406,813
- Jiyoung Ahn$11,904,977
- Zhiheng Pei$10,624,442
- Hemali Phatnani$31,805,811
- Fred Valentine$14,208,248
Others in their field
Top investigators on “Translating”
- Lee Marshall Nadler · Dana-Farber Cancer Inst$375,212,111
- Leonard Freedman · Leidos Biomedical Research, Inc.$362,430,297
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$293,499,096
- Steven E Reis · University Of Pittsburgh At Pittsburgh$281,789,183
- David Heimbrook · Leidos Biomedical Research, Inc.$265,645,121
- Gregory H Reaman · National Childhood Cancer Foundation$259,780,965
Research focus
TranslatingRisk FactorsDiagnosisIncidenceMalignant NeoplasmsDetectionCaringComplexEarly DiagnosisBiopsyMalignant - DescriptorDecision MakingImageBenignImproved OutcomeLesionDecision AidDiagnostic ImagingDiagnosticPreventModels And SimulationDecision ModelingAffectCharacteristics
Grant awards (15)
Optimizing Oral Cancer Screening and Precision Management of Potentially Malignant Oral Lesions$465,582
R01 · FY2025 · DE · contact PI
Optimizing Oral Cancer Screening and Precision Management of Potentially Malignant Oral Lesions$473,324
R01 · FY2024 · DE · contact PI
Tailored Screening for Urinary System Cancers in Patients with Chronic Kidney Disease$279,972
R01 · FY2024 · CA · contact PI
Tailored Screening for Urinary System Cancers in Patients with Chronic Kidney Disease$118,768
R01 · FY2024 · CA · contact PI
Tailored Screening for Urinary System Cancers in Patients with Chronic Kidney Disease$505,764
R01 · FY2023 · CA · contact PI
Optimizing Oral Cancer Screening and Precision Management of Potentially Malignant Oral Lesions$504,269
R01 · FY2023 · DE · contact PI
Optimizing Oral Cancer Screening and Precision Management of Potentially Malignant Oral Lesions$569,576
R01 · FY2022 · DE · contact PI
Tailored Screening for Urinary System Cancers in Patients with Chronic Kidney Disease$511,992
R01 · FY2022 · CA · contact PI
Optimizing Oral Cancer Screening and Precision Management of Potentially Malignant Oral Lesions$641,960
R01 · FY2021 · DE · contact PI
Patient-Centered Decision-Making for Management of Small Renal Tumors - Supplement$130,108
K07 · FY2021 · CA · contact PI
Patient-Centered Decision-Making for Management of Small Renal Tumors$180,576
K07 · FY2020 · CA · contact PI
Patient-Centered Decision-Making for Management of Small Renal Tumors$180,576
K07 · FY2019 · CA · contact PI
Patient-Centered Decision-Making for Management of Small Renal Tumors$180,576
K07 · FY2018 · CA · contact PI
Patient-Centered Decision-Making for Management of Small Renal Tumors$180,176
K07 · FY2017 · CA · contact PI
Patient-Centered Decision-Making for Management of Small Renal Tumors$179,672
K07 · FY2016 · CA · contact PI